Altitude sickness future or investigational therapies

Altitude sickness Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Altitude Sickness from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Altitude sickness future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Altitude sickness future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Altitude sickness future or investigational therapies
CDC on Altitude sickness future or investigational therapies
Altitude sickness future or investigational therapies in the news
Blogs on Altitude sickness future or investigational therapies
Directions to Hospitals Treating Altitude sickness
Risk calculators and risk factors for Altitude sickness future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

In order to help understand the factors that make some individuals susceptible to high altitude pulmonary edema (HAPE), the International HAPE Database was set up in 2004. Individuals who have previously suffered from HAPE can register with this confidential database in order to help researchers study the condition.